M.-C. Chen

Clinical outcomes and treatment response according to ATTR-CM risk in HFpEF: a real-world cohort study

Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized among patients with heart failure with preserved ejection fraction (HFpEF). The ATTR-CM score has been proposed as a screening tool to identify patients at high risk of ATTR-CM. However, it remains uncertain whether a high ATTR-CM risk prof...